Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Interesting read ..........
View:
Comment by subaru1 on Oct 31, 2023 10:58am
I agree good reading but also look at the competition side of all the related companies, we are not alone.
Comment by okgonow on Oct 31, 2023 1:26pm
great read amazed they didnt mention FDA aproval
Comment by mdjbrown on Oct 31, 2023 2:39pm
Could be as a Swiss pharma outfit they are not targetting the US for distribution, and therefore wouldnt require it.   With Europe requiring doctors perscriptions for cbd "medicine", they would do very well in that market.  I really think the countries that are mandating CBD medicines as doctor prescribed only, are the markets that need to be high on Medipharms list, as I ...more  
Comment by okgonow on Oct 31, 2023 2:50pm
Could be as a Swiss pharma outfit they are not targetting the US for distribution, and therefore wouldnt require it.   With Europe requiring doctors perscriptions for cbd "medicine", they would do very well in that market.  I really think the countries that are mandating CBD medicines as doctor prescribed only, are the markets that need to be high on Medipharms list, as I ...more  
Comment by mdjbrown on Oct 31, 2023 4:01pm
Wasnt worth it to him okgonow, and probably why doctors in Canada are not lining up to get educated on the subject as CBD medicines are not mainstream with the exception of Epidiolex. There will be a time and place but as long as recreational use crosses pathes with pharma use, I can see hurdles.
Comment by okgonow on Oct 31, 2023 4:33pm
lots of other situations where rec use has crossed with Pharma use and it makes no difference... EG. :Opium .....being the big one even Heroin (Heroin is used medically in several countries to relieve pain, such as during childbirth or a heart attack, as well as in opioid replacement therapy)
Comment by Solid1 on Oct 31, 2023 4:45pm
Thank you for this great article that also dispels the myth of synthetic cannabinoids and highlights the benefits of natural cannabinoids. Thanks for sharing 
Comment by subaru1i on Nov 01, 2023 3:28pm
I extract the 800 times more potent acid form of say CBD or THC and stabilize with an esther for my pharma partner.   That is now in fact a synthetic cannabinoid as well, albeit with natural origins.   
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities